A new trading day began on Tuesday, with Mind Medicine Inc (NASDAQ: MNMD) stock price down -6.02% from the previous day of trading, before settling in for the closing price of $7.14. MNMD’s price has ranged from $4.70 to $10.44 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Meanwhile, its annual earnings per share averaged 5.67%. With a float of $72.82 million, this company’s outstanding shares have now reached $75.51 million.
Let’s determine the extent of company efficiency that accounts for 74 employees. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Mind Medicine Inc (MNMD) Insider Activity
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Mind Medicine Inc is 3.61%, while institutional ownership is 54.05%. The most recent insider transaction that took place on Mar 25 ’25, was worth 142,942. In this transaction Chief Executive Officer of this company sold 21,208 shares at a rate of $6.74, taking the stock ownership to the 856,556 shares. Before that another transaction happened on Mar 25 ’25, when Company’s Chief Medical Officer sold 6,836 for $6.74, making the entire transaction worth $46,075. This insider now owns 446,177 shares in total.
Mind Medicine Inc (MNMD) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around 5.67% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 9.97% during the next five years compared to 12.11% growth over the previous five years of trading.
Mind Medicine Inc (NASDAQ: MNMD) Trading Performance Indicators
Here are Mind Medicine Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 7.27.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.04, a number that is poised to hit -0.37 in the next quarter and is forecasted to reach -1.55 in one year’s time.
Technical Analysis of Mind Medicine Inc (MNMD)
Looking closely at Mind Medicine Inc (NASDAQ: MNMD), its last 5-days average volume was 0.96 million, which is a drop from its year-to-date volume of 1.59 million. As of the previous 9 days, the stock’s Stochastic %D was 10.48%. Additionally, its Average True Range was 0.45.
During the past 100 days, Mind Medicine Inc’s (MNMD) raw stochastic average was set at 35.04%, which indicates a significant increase from 2.62% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 43.61% in the past 14 days, which was lower than the 80.92% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $6.61, while its 200-day Moving Average is $6.78. However, in the short run, Mind Medicine Inc’s stock first resistance to watch stands at $7.03. Second resistance stands at $7.35. The third major resistance level sits at $7.53. If the price goes on to break the first support level at $6.53, it is likely to go to the next support level at $6.35. Should the price break the second support level, the third support level stands at $6.03.
Mind Medicine Inc (NASDAQ: MNMD) Key Stats
With a market capitalization of 506.96 million, the company has a total of 75,553K Shares Outstanding. Currently, annual sales are 0 K while annual income is -108,680 K. The company’s previous quarter sales were 0 K while its latest quarter income was -23,350 K.
